So Much for That Biotech ETF Bubble
August 20, 2014 at 12:28 PM EDT
It seems like only yesterday that there was a cacophony of criticism and doubt from naysayers regarding biotechnology stock and exchange traded funds. In reality, “yesterday” was the first quarter when the usually pricey biotech sector soared to valuations that were double its already high...